Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
Witness the elegance of the cosmic butterfly in a remarkable telescope photo - 2Nurturing Hacks: Shrewdness from Experienced Mothers and Fathers
- 3Remain Fit and Sound with These Exercise Fundamentals
- 4Songbirds swap colorful plumage genes across species lines among their evolutionary neighbors
- 5New subclade K flu strain raises concerns: What families should know
- Vote In favor of Your #1 sort of film
- Vote In favor of Feasible Way You Prescribe to Shop for Garments
- An Aide On Upgrading Your FICO rating
- Tatiana Schlossberg's diagnosis puts spotlight on leukemia: What to know
- Fundamental Monetary Guidance for Going into Business
- Vote in favor of Your #1 BWM Vehicles
- Step by step instructions to Keep up with Ideal Oral Cleanliness at Home
- Reviving Your Home with Nutritious Indoor Plants
- Understanding Various Sorts of Financial balances: An Extensive Outline
